← FDA DRUG APPROVALS

FDA ANDA · ANDA075836

CALCITRIOL

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA075836
TYPE
ANDA
ORIGINAL APPROVAL
2002-12-31
LATEST ACTION
2008-11-24
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CALCITRIOLDiscontinued
CALCITRIOL 0.001MG/ML · INJECTABLE · INJECTION
CALCITRIOLDiscontinued
CALCITRIOL 0.002MG/ML · INJECTABLE · INJECTION

Approval history

2008-11-24Labeling · Supplement 5AP
2003-08-06Labeling · Supplement 2AP
2002-12-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →